cancer

Syntropy, a Merck KGaA – Palantir JV aiming to apply big data to cancer research
Syntropy, a Merck KGaA – Palantir JV aiming to apply big data to cancer research
GoinPharma
Merck KGaA
Palantir Technologies
Syntropy
cancer
Big Data
Flag link:
Merck KGaA Enters Field of Big Data With Joint Venture With Palantir Technologies
Merck KGaA Enters Field of Big Data With Joint Venture With Palantir Technologies
BioSpace
Big Data
Merck KGaA
Palantir Technologies
Syntropy
cancer
Flag link:
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
Flag link:
Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks
Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks
BioSpace
cancer
R&D
drug development
Boehringer Ingelheim
Epizyme
Flag link:
Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular Health
Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular Health
BioSpace
Viagra
Pfizer
Cialis
Eli Lilly
erectile dysfunction
cancer
Cardiovascular
drug repurposing
Flag link:
A $3 Billion Startup's Shares Gain On Hopes For A Cancer Blood Test
A $3 Billion Startup's Shares Gain On Hopes For A Cancer Blood Test
Forbes
Guardant Health
diagnostics
cancer
Flag link:
‘We ran out of money’: High-profile startup seeking to connect patients with clinical trials shuts down
‘We ran out of money’: High-profile startup seeking to connect patients with clinical trials shuts down
Stat
Driver
cancer
clinical trials
mobile apps
patients
Flag link:
GSK’s systemic STING agonist could overcome delivery hurdles
GSK’s systemic STING agonist could overcome delivery hurdles
BioCentury
GSK
STING agonists
cancer
Flag link:
Which media reaches cancer patients? Depends on their diagnosis: report
Which media reaches cancer patients? Depends on their diagnosis: report
Fierce Pharma
cancer
media
Flag link:
How A Small Scottish Biotech Firm Could Win A Decisive Battle Against Cancer
How A Small Scottish Biotech Firm Could Win A Decisive Battle Against Cancer
Forbes
Nucana
Scotland
cancer
drug development
Flag link:
Still Seeking Pharma Partner, Phoenix Bio Adds $1M in Angel Funding
Still Seeking Pharma Partner, Phoenix Bio Adds $1M in Angel Funding
Xconomy
Phoenix Biotechnology
cancer
PBI-05204
Flag link:
FDA lists 200 cancer targets that could require pediatric trials
FDA lists 200 cancer targets that could require pediatric trials
BioCentury
cancer
FDA
pediatric cancer
clinical trials
Flag link:
FDA mandates pediatric trials for 200 cancer targets
FDA mandates pediatric trials for 200 cancer targets
BioCentury
FDA
pediatric
clinical trials
oncology
cancer
Flag link:
3 Big Pharma Stocks Racing Along the Road to China
3 Big Pharma Stocks Racing Along the Road to China
Motley Fool
China
cancer
Pfizer
AstraZeneca
JNJ
Flag link:
Standardization Of Drug Compendia That Support Off-Label Use Reimbursement Of Cancer Drugs
Standardization Of Drug Compendia That Support Off-Label Use Reimbursement Of Cancer Drugs
Forbes
off-label
oncology
oncologists
cancer
CMS
Flag link:
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic
Xconomy
cancer
VelosBio
Arix Bioscience
Flag link:
Roche aims to improve cancer treatments with DNA blood test
Roche aims to improve cancer treatments with DNA blood test
Pharmaforum
Roche
diagnostics
cancer
personalized medicine
solid tumors
FoundationOne Liquid
Flag link:
Release: AbbVie Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
Release: AbbVie Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
BioSpace
AbbVie
cancer
pediatric cancer
philanthropy
Flag link:
Preparing for the incoming wave of biosimilars in oncology
Preparing for the incoming wave of biosimilars in oncology
ESMO Open
biosimilars
oncology
cancer
Flag link:
GSK-backed scientific team at UCSF says they found the immortality switch in cancer cells — and know how to turn it off
GSK-backed scientific team at UCSF says they found the immortality switch in cancer cells — and know how to turn it off
Endpoints
cancer
GSK
R&D
UCSF Medical Center
Flag link:

Pages